A study for a 30 year old man who takes Xolair - from FDA reports


Summary

310 males aged 30 (±5) who take the same drug are studied. This is a personalized study for a 30 year old male patient who has Urticaria Chronic. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On May, 18, 2017

310 males aged 30 (±5) who take Xolair are studied.


Number of reports submitted per year:

Xolair for a 30-year old man.

Information of the patient in this study:

  • Age: 30
  • Gender: male
  • Conditions: Urticaria Chronic
  • Drugs taken:
    • Xolair (omalizumab)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • cough
  • fatigue
  • anaphylaxis
  • breathing difficulty
  • throat tightness
  • dizziness
  • hyperventilation
  • hypoaesthesia
  • loss of consciousness
  • throat irritation
1 - 6 months:
  • itching
  • chest pain
  • urticaria
  • breathing difficulty
  • asthma
  • wheezing
  • hypersensitivity
  • anaphylaxis
  • angioedema
  • drug ineffective
6 - 12 months:
  • joint pain
  • oedema peripheral
  • abdominal pain upper
  • amyotrophy
  • fatigue
  • gastric ulcer
  • indigestion
  • swallowing difficulty
  • asthma
  • malaise
1 - 2 years:
  • asthma
  • drug ineffective
  • chest pain
  • weight increased
  • hypoventilation
  • malaise
  • nasopharyngitis
  • dry skin
  • productive cough
  • gastroenteritis viral
2 - 5 years:
  • itching
  • dizziness
  • hypersensitivity
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • asthma
  • breathing difficulty
  • nasopharyngitis
  • fatigue
  • headache
  • high blood pressure
  • heart rate increased
  • weight increased
  • hypersensitivity
  • cough

Top conditions involved for these people *:

  • Asthma (242 people, 78.06%)
  • Hypersensitivity (10 people, 3.23%)
  • Rhinitis (9 people, 2.90%)
  • Urticaria Chronic (6 people, 1.94%)
  • Urticaria (5 people, 1.61%)

Top co-used drugs for these people *:

  • Singulair (67 people, 21.61%)
  • Symbicort (56 people, 18.06%)
  • Ventolin (30 people, 9.68%)
  • Prednisone (26 people, 8.39%)
  • Prednisolone (22 people, 7.10%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Xolair, Urticaria chronic

You may be interested in these reviews

More reviews for: Xolair, Urticaria chronic